Literature DB >> 19076657

Diagnosis and treatment of the menstrual migraine patient.

Stephen D Silberstein1, Susan L Hutchinson.   

Abstract

Women presenting with recurrent disabling headache frequently have migraine; but physicians need to rule out other headache disorders before they reach a diagnosis of migraine with or without aura. Many women who experience migraine in close association to their menstrual cycle may meet the diagnostic criteria for either menstrually related migraine (MRM), or pure menstrual migraine (PMM). Once an accurate diagnosis is made, treatment may be established to best suit the individual needs of that patient. Most women will find that migraine associated with hormone fluctuations respond well to standard treatment approaches including pharmacological and nonpharmacological treatments. Pharmacological approaches include acute, preventive, and short-term prophylaxis. Herein we review the difference between non-menstrual migraine, PMM, and MRM and identify effective treatment strategies for appropriate management of migraine associated with hormonal fluctuations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076657     DOI: 10.1111/j.1526-4610.2008.01309.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  2 in total

1.  Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.

Authors:  Gianni Allais; Gennaro Bussone; Giovanni D'Andrea; Franca Moschiano; Florindo d'Onofrio; Fabio Valguarnera; Gian Camillo Manzoni; Licia Grazzi; Rita Allais; Chiara Benedetto; Giancarlo Acuto
Journal:  Cephalalgia       Date:  2010-07-26       Impact factor: 6.292

2.  Acupuncture as prophylaxis for menstrual-related migraine: study protocol for a multicenter randomized controlled trial.

Authors:  Xiao-Zhe Zhang; Lei Zhang; Jia Guo; Lin Zeng; Yi Yang; Tao Zhang; Guang-Xia Shi; Hui-Lin Liu; Lin-Peng Wang
Journal:  Trials       Date:  2013-11-06       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.